Comparison Chart Protagonist Therapeutics, Inc.
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 130.95 USD | -2.55% |
|
-0.83% | +49.93% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -2.55% | -0.83% | +49.93% | +54.77% | +266.40% | 8.55B |
- Stock Market
- Stocks
- PTGX Stock
- Charts Protagonist Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















